Patents by Inventor Eun-Kyung Hong

Eun-Kyung Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080085333
    Abstract: The present invention relates to a composition comprising a water or organic solvent extract of Anemarrhena asphodeloides and Aralia elata, and the use thereof. The composition has a preventive or therapeutic effect on inflammatory skin diseases and an antibacterial effect against Propionibacterium acnes.
    Type: Application
    Filed: October 18, 2005
    Publication date: April 10, 2008
    Applicant: MEDVILL CO., LTD.
    Inventors: Eun-Kyung Hong, Young-Shin Chung
  • Patent number: 6827950
    Abstract: The present invention relates to Aralia extracts and a therapeutic agent comprising Aralia extracts as an active ingredient. The composition and therapeutic agent according to the present invention are effective in preventing cataract, delaying the development of cataract, and treating cataract. According to the present invention, extracts of Aralia are obtained by extraction with alcohol. Addition of myo-inositol or taurine to the extracts will result in a synergistic effect in the treatment of cataract. In addition, oral administration of beverages, galenicals, and nutraceuticals, which comprise Aralia extracts as an active ingredient, will be effective in prevention, delay and treatment of cataract caused by complications of diabetes. Aralia extracts will have the same effect in the case where they are used as an ophthalmic agent. They can also be used as an eye drop or an eye ointment.
    Type: Grant
    Filed: August 15, 2002
    Date of Patent: December 7, 2004
    Assignee: Medvill Co., Ltd.
    Inventors: Eun-Kyung Hong, Young-Shin Chung, Yeong-Bok Han, Yun Hui Choi, Seong-Jin Kim, Hae-Ri Kim, Bu-Hyeon Kang
  • Publication number: 20040033274
    Abstract: The present invention relates to Aralia extracts and a therapeutic agent comprising Aralia extracts as an active ingredient. The composition and therapeutic agent according to the present invention are effective in preventing cataract, delaying the development of cataract, and treating cataract. According to the present invention, extracts of Aralia are obtained by extraction with alcohol. Addition of myo-inositol or taurine to the extracts will result in a synergistic effect in the treatment of cataract. In addition, oral administration of beverages, galenicals, and nutraceuticals, which comprise Aralia extracts as an active ingredient, will be effective in prevention, delay and treatment of cataract caused by complications of diabetes. Aralia extracts will have the same effect in the case where they are used as an ophthalmic agent. They can also be used as an eye drop or an eye ointment.
    Type: Application
    Filed: August 15, 2002
    Publication date: February 19, 2004
    Applicant: Medvill Co., Ltd.
    Inventors: Eun-Kyung Hong, Young-Shin Chung
  • Patent number: 6589572
    Abstract: A composition for treating hypertension and lowering cholesterol is provided which contains the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient thus lowering and maintaining blood pressure substantially constant. Also provided is a method for preparing composition containing the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: July 8, 2003
    Assignee: Medvill Co., Ltd.
    Inventors: Eun Kyung Hong, Young Shin Chung
  • Publication number: 20030003165
    Abstract: A composition for treating hypertension and lowering cholesterol is provided which contains the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient thus lowering and maintaining blood pressure substantially constant. Also provided is a method for preparing composition containing the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient.
    Type: Application
    Filed: June 14, 2001
    Publication date: January 2, 2003
    Applicant: MEDVILL CO., LTD.
    Inventors: Eun Kyung Hong, Young Shin Chung
  • Patent number: 6193977
    Abstract: The present invention is directed to a pharmaceutical composition comprising an extract of a mixture of Anemarrhena Rhizoma, a member of the family Liliaceae and, Phellodendron bark, a member of the family Rutaceae that produces analgesic and anti-inflammatory effects, and its preparing method. The present invention is applicable to act on inflammation and pain, for example, chronic gastritis, arthralgia, benign prostate hyperplasia, chronic and recurrent cystitis, cervical disc, degenerative joint arthritis, rheumatoid arthritis, tennis elbow, osteoportotic pain, migraine, diabetic neuropathy pain, right flank pain, etc. The present invention a crude extract suitable for long-period administration with less side effects. Also, the present invention does not lead to dependency or resistance.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: February 27, 2001
    Assignee: Medvill Co., Ltd.
    Inventors: Young-Bok Han, Eun-Kyung Hong, Young-Shin Chung, Sung-Jin Kim, Kyung-Yung Lee, Young-Lok Shin
  • Patent number: 6113909
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of hepatitis C which comprises a mixed extract, particularly a mixed aqueous extract or a mixed alcohol extract, of Phellodendron amurense RUPRECHT cortex and Patrinia scabiosaefolia FISCH. as an active ingredient. The mixed extract according to the present invention exhibits an anti-viral activity for hepatitis C and help prevents hepatic cirrhosis orginated from hepatitis C, and further treats hepatitis and hepatic cirrhosis by potentiating the immunological function to inhibit the proliferation of hepatitis C virus and stimulating the proliferation of T helper cells to increase the host immune system. Furthermore, the mixed extract of the present invention is a mixed extract of natural plants characterized in that it does not exhibit any side effects nor drug resistance, and its activity is maintained even when used for a long period.
    Type: Grant
    Filed: April 6, 1999
    Date of Patent: September 5, 2000
    Assignees: Young Hee Kim, Young Bok Han
    Inventors: Young Bok Han, Eun Kyung Hong, Young Shin Chung, Bo Im Yoo, Sang Geon Kim, Kyung Yung Lee
  • Patent number: 5928645
    Abstract: The present invention provides a extracted substance from a mixture of a non-fat starch from Ricini semen and a root of coptis Sp. This substance is suitable for use in the therapeutic applications of AIDS.
    Type: Grant
    Filed: September 13, 1995
    Date of Patent: July 27, 1999
    Assignee: Young Bok Han & Korean Assoc. of Creation Research
    Inventors: Young Bok Han, Jeong Jo Mun, Hong Ki Kyung, Jong Bae Kim, Kyung Tae Kim, Hae Ri Kim, Jeong Han Kim, Hyun Gil Shin, Kyung Rae Kim, Eun Kyung Hong, Choon Won Kim
  • Patent number: 5891864
    Abstract: The present invention relates to an anti-cancer composition containing acridine derivatives and guanosine compounds. In the composition of the present invention, the acridine derivative and the guanosine compound are present in the weight ratio of 1:0.1-5.0, preferably 1:0.3-3.0 and more preferably 1:0.5-1.5. In the composition of the present invention, most preferably the acridine derivative is acriflavine neutral and the guanosine compound is guanosine hydrate. Although acridine derivatives and guanosine compounds used as an active ingredient in the present composition have substantially no anti-cancer effect when they are used individually, the combination of acriflavine neutral and guanosine hydrate which potentiates the effect of acriflavine neutral, i.e. the composition(AG60) according to the present invention, exhibits reduced toxicity and increased anti-cancer effect in comparison to the use of acriflavine neutral or guanosine hydrate alone.
    Type: Grant
    Filed: November 3, 1995
    Date of Patent: April 6, 1999
    Assignees: Yung Bok Han, Tae Rim Pharm. Co., Ltd.
    Inventors: Yung Bok Han, Hong Ki Kyung, Chun Won Kim, E Tay Ahn, Jong Bae Kim, Hyo Suk Lee, Kyung Yung Lee, Eun Kyung Hong, Hee Sook Choi, Sang Geon Kim, Bo Im Yoo, Hae Kyung Kwon